$2500 | Single User
$5000 | Site License
$7500 | Enterprise License

Herpes Labialis (Oral Herpes) Global Clinical Trials Review, H1, 2016
[Published by Global Data]

Published by Global Data: 29 Feb 2016 | 18132 | In Stock
Related Topics: Clinical Trials

Introduction

Herpes Labialis (Oral Herpes) Global Clinical Trials Review, H1, 2016

Summary

GlobalData's clinical trial report, “Herpes Labialis (Oral Herpes) Global Clinical Trials Review, H1, 2016" provides an overview of Herpes Labialis (Oral Herpes) clinical trials scenario. This report provides top line data relating to the clinical trials on Herpes Labialis (Oral Herpes). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents
for Herpes Labialis (Oral Herpes) Global Clinical Trials Review, H1, 2016 [Published by Global Data]

  • Table of Contents

    Table of Contents 2

    List of Tables 3

    List of Figures 4

    Report Guidance 5

    Clinical Trials by Region 6

    Clinical Trials and Average Enrollment by Country 7

    Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

    Top Five Countries Contributing to Clinical Trials in Europe 11

    Top Countries Contributing to Clinical Trials in North America 12

    Top Countries Contributing to Clinical Trials in Middle East and Africa 13

    Top Countries Contributing to Clinical Trials in Central and South America 14

    Clinical Trials by G7 Countries: Proportion of Herpes Labialis (Oral Herpes) to Infectious Disease Clinical Trials 15

    Clinical Trials by Phase in G7 Countries 16

    Clinical Trials in G7 Countries by Trial Status 17

    Clinical Trials by E7 Countries: Proportion of Herpes Labialis (Oral Herpes) to Infectious Disease Clinical Trials 18

    Clinical Trials by Phase in E7 Countries 19

    Clinical Trials by Phase 20

    In Progress Trials by Phase 21

    Clinical Trials by Trial Status 22

    Clinical Trials by End Point Status 23

    Subjects Recruited Over a Period of Time 24

    Clinical Trials by Sponsor Type 25

    Prominent Sponsors 26

    Top Companies Participating in Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials 27

    Prominent Drugs 29

    Clinical Trial Profile Snapshots 30

    Appendix 57

    Abbreviations 57

    Definitions 57

    Research Methodology 58

    Secondary Research 58

    About GlobalData 59

    Contact Us 59

    Disclaimer 59

    Source 60

List Of Tables
in Herpes Labialis (Oral Herpes) Global Clinical Trials Review, H1, 2016 [Published by Global Data]

List of Tables

Herpes Labialis (Oral Herpes) Therapeutics, Global, Clinical Trials by Region, 2016* 6

Herpes Labialis (Oral Herpes) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 8

Herpes Labialis (Oral Herpes) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9

Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 10

Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 11

Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, North America, Top Countries, 2016* 12

Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 13

Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, Central and South America, Top Countries, 2016* 14

Proportion of Herpes Labialis (Oral Herpes) to Infectious Disease Clinical Trials, G7 Countries (%), 2016* 15

Herpes Labialis (Oral Herpes) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16

Herpes Labialis (Oral Herpes) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 17

Proportion of Herpes Labialis (Oral Herpes) to Infectious Disease Clinical Trials, E7 Countries (%), 2016* 18

Herpes Labialis (Oral Herpes) Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19

Herpes Labialis (Oral Herpes) Therapeutics, Global, Clinical Trials by Phase, 2016* 20

Herpes Labialis (Oral Herpes) Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 21

Herpes Labialis (Oral Herpes) Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22

Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23

Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24

Herpes Labialis (Oral Herpes) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 25

Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26

Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 28

Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29

List Of Figures, Charts and Diagrams
in Herpes Labialis (Oral Herpes) Global Clinical Trials Review, H1, 2016 [Published by Global Data]

List of Figures

Herpes Labialis (Oral Herpes) Therapeutics, Global, Clinical Trials by Region (%), 2016* 6

Herpes Labialis (Oral Herpes) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7

Herpes Labialis (Oral Herpes) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9

Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 10

Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 11

Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 12

Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2016* 13

Proportion of Herpes Labialis (Oral Herpes) to Infectious Disease Clinical Trials, G7 Countries (%), 2016* 15

Herpes Labialis (Oral Herpes) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16

Herpes Labialis (Oral Herpes) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 17

Proportion of Herpes Labialis (Oral Herpes) to Infectious Disease Clinical Trials, E7 Countries (%), 2016* 18

Herpes Labialis (Oral Herpes) Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19

Herpes Labialis (Oral Herpes) Therapeutics, Global, Clinical Trials by Phase (%), 2016* 20

Herpes Labialis (Oral Herpes) Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 21

Herpes Labialis (Oral Herpes) Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22

Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23

Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24

Herpes Labialis (Oral Herpes) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 25

Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26

Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27

Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29

GlobalData Methodology 58

Additional Details

Publisher

Global Data

Publisher Information

Reference

18132 | GDHC3245CTIDB

Number of Pages

60

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Global Herpes simplex Partnering 2010 to 2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Nov 2016 by Current Partnering USD $1,495 More Info
Global Herpes simplex Partnering 2010 to 2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Oct 2016 by Current Partnering USD $1,495 More Info
World Herpes Diagnostics Market: Emerging Opportunities and Growth Strategies
The report presents a detailed analysis of the Herpes diagnostics market in the US, Europe, (France,...
12 Jul 2016 by Venture Planning Group (VPG) USD $5,450 More Info
Herpes Simplex Virus (HSV) Diagnostic Tests - Medical Devices Pipeline Assessment, 2016
Herpes Simplex Virus (HSV) Diagnostic Tests - Medical Devices Pipeline Assessment, 2016SummaryGlobal...
01 Jul 2016 by Global Data USD $2,500 More Info
Herpes Simplex Virus (HSV) Diagnostic Tests - Medical Devices Pipeline Assessment, 2016
Herpes Simplex Virus (HSV) Diagnostic Tests - Medical Devices Pipeline Assessment, 2016SummaryGlobal...
01 Jul 2016 by Global Data USD $2,500 More Info
US Sexually-Transmitted Diseases (STDs): Chancroid, Chlamydia, Gonorrhea, Herpes, HPV, Syphilis--Supplier Shares by Test, Competitive Strategies, Country Volume and Sales Segment Forecasts
Complete report ,500.  DataPack (test volumes, sales forecasts, supplier shares) ,900.This ...
01 Jul 2016 by Venture Planning Group (VPG) USD $4,500 More Info
Herpes Diagnostic Testing Market
The report presents a detailed analysis of the Herpes diagnostics market in the US, Europe, (France,...
01 Jul 2016 by Venture Planning Group (VPG) USD $5,450 More Info
Herpes: US, Europe, Japan--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers
The report presents a detailed analysis of the Herpes diagnostics market in the US, Europe, (France,...
23 Jun 2016 by Venture Planning Group (VPG) USD $4,350 More Info
Genital Herpes Global Clinical Trials Review, H1, 2016
Genital Herpes Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical trial report, “Ge...
29 Feb 2016 by Global Data USD $2,500 More Info
Herpes Zoster (Shingles) Global Clinical Trials Review, H1, 2016
Herpes Zoster (Shingles) Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical trial r...
29 Feb 2016 by Global Data USD $2,500 More Info

This report is published by Global Data

Download Free Report Summary PDF

Herpes Labialis (Oral Herpes) Global Clinical Trials Review, H1, 2016 [Published by Global Data] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...